Robertson W R, Reader S C, Davison B, Frost J, Mitchell R, Kayte R, Lambert A
Postgrad Med J. 1985;61 Suppl 3(721):145-51.
Dispersed guinea-pig adrenal cells or mouse Leydig cells were stimulated with a saturating dose of adrenocorticotrophin (ACTH, 50 ng/1) or luteinizing hormone (LH, 5IU/1), respectively. The incubations were performed in the presence of increasing concentrations (10(-9) - 5 X 10(-4)mol/l) of the anaesthetic agents propofol, thiopentone and etomidate. At the end of this stimulation period, cortisol (from the adrenal preparation) or testosterone (from the Leydig cell culture) were assayed by radioimmunoassay. Propofol, thiopentone and etomidate all inhibited ACTH-stimulated cortisol secretion in a dose-related fashion. Similar inhibition of LH-stimulated testosterone output was found with propofol and thiopentone whereas etomidate was without effect at any concentration employed, an observation in accordance with its known site of action, 11 beta-hydroxylase, an enzyme which is not involved in the biosynthesis of testosterone. The concentration (mumol/l) of anaesthetics which gave 50% inhibition (ED50) of ACTH-stimulated cortisol secretion was 0.1 +/- 0.002 (n = 7), 160 +/- 18 (n = 3) and 170 +/- 18 (n = 3) (mean +/- s.e.m.) for etomidate, thiopentone and propofol, respectively. The corresponding values for the LH stimulated testosterone output from the Leydig cell preparations were 186 (thiopentone) and 180 (propofol) mumol/l. In a separate series of experiments adrenal cells were stimulated with (a) the cortisol precursor steroids (all at 10(-5)mol/l) pregnenolone, 17-hydroxypregnenolone, progesterone, 17-hydroxyprogesterone and 11-deoxycortisol, (b) dibutyryl cAMP (10(-3)mol/l) or (c) ACTH (100 ng/l) in the presence and absence of either etomidate (5 X 10(-5)mol/l), propofol (2.5 X 10(-4)mol/l) or thiopentone (5 X 10(-4)mol/l). All the stimulators increased cortisol production by > 7-fold over that seen in their absence. Propofol depressed ACTH and dibutyryl cAMP induced cortisol output by > 60% (P < 0.05) but was without effect when the steroid precursors were used, suggestive of an inhibition between the sequence involving ACTH binding -> pregnenolone production. In contrast, etomidate and thiopentone reduced cortisol secretion by > 40% (P < 0.05) regardless of the stimulator used, indicating that at least one site of action was at the level of the final enzymic step of cortisol synthesis, i.e. 11beta-hydroxylase.
分别用饱和剂量的促肾上腺皮质激素(促肾上腺皮质激素,50 ng/1)或促黄体生成素(促黄体生成素,5IU/1)刺激分散的豚鼠肾上腺细胞或小鼠睾丸间质细胞。在麻醉剂丙泊酚、硫喷妥钠和依托咪酯浓度不断增加(10⁻⁹ - 5×10⁻⁴mol/l)的情况下进行孵育。在该刺激期结束时,通过放射免疫分析法测定皮质醇(来自肾上腺制剂)或睾酮(来自睾丸间质细胞培养物)。丙泊酚、硫喷妥钠和依托咪酯均以剂量相关方式抑制促肾上腺皮质激素刺激的皮质醇分泌。丙泊酚和硫喷妥钠对促黄体生成素刺激的睾酮分泌有类似抑制作用,而依托咪酯在所用的任何浓度下均无作用,这一观察结果与其已知作用位点11β - 羟化酶一致,该酶不参与睾酮的生物合成。产生促肾上腺皮质激素刺激的皮质醇分泌50%抑制(ED50)的麻醉剂浓度(μmol/l),依托咪酯、硫喷妥钠和丙泊酚分别为0.1±0.002(n = 7)、160±18(n = 3)和170±18(n = 3)(平均值±标准误)。来自睾丸间质细胞制剂的促黄体生成素刺激的睾酮分泌的相应值为186(硫喷妥钠)和180(丙泊酚)μmol/l。在另一系列实验中,在存在和不存在依托咪酯(5×10⁻⁵mol/l)、丙泊酚(2.5×10⁻⁴mol/l)或硫喷妥钠(5×10⁻⁴mol/l)的情况下,用(a)皮质醇前体类固醇(均为10⁻⁵mol/l)孕烯醇酮、17 - 羟孕烯醇酮、孕酮、17 - 羟孕酮和11 - 脱氧皮质醇,(b)二丁酰环磷腺苷(10⁻³mol/l)或(c)促肾上腺皮质激素(100 ng/l)刺激肾上腺细胞。所有刺激剂使皮质醇产生量比未加刺激剂时增加了7倍以上。丙泊酚使促肾上腺皮质激素和二丁酰环磷腺苷诱导的皮质醇分泌减少>60%(P < 0.05),但使用类固醇前体时无作用,提示在涉及促肾上腺皮质激素结合→孕烯醇酮产生的序列之间存在抑制作用。相比之下,依托咪酯和硫喷妥钠无论使用何种刺激剂均使皮质醇分泌减少>40%(P < 0.05),表明至少一个作用位点在皮质醇合成的最终酶促步骤水平,即11β - 羟化酶。